In this retrospective cohort analysis, researchers aimed to identify key predictors of trial enrollment among cancer patients.

Good day, and thank you for standing by. Welcome to the uniQure Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...

Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...

To inform continued development of the novel immune agent GEN-1, we compared ovarian cancer patients' end points from a neoadjuvant single-arm phase IB study with those of similar historic clinical ...